Overview

Eze/Simva Switch Study in Diabetics (0653A-807)

Status:
Completed
Trial end date:
2005-10-14
Target enrollment:
Participant gender:
Summary
A study to assess the effectiveness and tolerability of MK0653A and MK0653A versus Atorvastatin in lowering LDL-C levels.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Atorvastatin
Atorvastatin Calcium
Ezetimibe
Ezetimibe, Simvastatin Drug Combination
Simvastatin